Edition:
United States

Vita 34 AG (V3VGn.DE)

V3VGn.DE on Xetra

4.75EUR
8:37am EST
Change (% chg)

€-0.13 (-2.66%)
Prev Close
€4.88
Open
€4.77
Day's High
€4.77
Day's Low
€4.75
Volume
10,280
Avg. Vol
9,205
52-wk High
€5.47
52-wk Low
€3.66

V3VGn.DE

Chart for V3VGn.DE

About

Vita 34 AG, is a Germany-based company that operates as an umbilical cord blood bank. It operates through Stem Cell Storage and Biotechnology segments. The Stem Cell Storage segment collects, processes, and stores stem cells from umbilical cord blood and umbilical cord tissue, as well as develops cell therapy procedures. The... (more)

Overall

Beta: 0.06
Market Cap(Mil.): €14.77
Shares Outstanding(Mil.): 3.03
Dividend: 0.16
Yield (%): 3.28

Financials

  V3VGn.DE Industry Sector
P/E (TTM): 8.89 38.10 30.65
EPS (TTM): 0.55 -- --
ROI: 4.14 8.83 15.23
ROE: 6.67 12.38 16.56

BRIEF-Vita 34 9-mth revenues up 16.9 pct to 12.0 million euros

* Was able to increase revenues in first nine months of 2016 by 16.9 percent to 12.0 million euros ($12.72 million) (first 9 months 2015: 10.3 million euros)

Nov 21 2016

BRIEF-Vita 34 expands its business in China

* Cooperation agreement was signed by CEO André Gerth, and CEO of Avic Biology, Wang Hualin Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 20 2016

BRIEF-Vita 34 H1 revenue up 25 pct at 8.0 million euros

* H1 revenue increased by 25 percent from some 6.4 million euros to 8.0 million euros ($9.07 million)

Aug 23 2016

Earnings vs. Estimates